Terms: = Prostate cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Clinical Outcome
2 results:
1. Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice.
Barra S; Guarnieri A; di Monale E Bastia MB; Marcenaro M; Tornari E; Belgioia L; Magrini SM; Ricardi U; Corvò R
Radiol Med; 2021 Jan; 126(1):142-146. PubMed ID: 32415472
[TBL] [Abstract] [Full Text] [Related]
2. prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer.
Paoluzzi M; Losa A; Cerboneschi V; Colosimo C; Fontana N; Mangili P; Mignogna M; Nava L; Ravaglia V
Brachytherapy; 2017; 16(5):1000-1006. PubMed ID: 28642046
[TBL] [Abstract] [Full Text] [Related]
